In this issue:
Age-groups and use of antiviral treatment
Efficacy of nirmatrelvir-ritonavir
Comparing monotherapy to combination therapy
COVID-19 vaccination and birth outcomes
Antiviral treatment for Omicron variant
Risk of BA.5 reinfection
Amubarvimab/romlusevimab and long COVID
Prevalence of antiviral resistance
Adjunctive statin therapy efficacy
Functional and cognitive status 1-year post infection
Please login below to download this issue (PDF)